Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 23
2021 46
2022 35
2023 32
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.
Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M, Hushmandi K, Sethi G, Zarrabi A, Kumar AP, Tan SC, Papadakis M, Alexiou A, Islam MA, Mostafavi E, Ashrafizadeh M. Paskeh MDA, et al. Among authors: hushmandi k. J Hematol Oncol. 2022 Jun 28;15(1):83. doi: 10.1186/s13045-022-01305-4. J Hematol Oncol. 2022. PMID: 35765040 Free PMC article. Review.
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions.
Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Entezari M, Taheriazam A, Hushmandi K. Hashemi M, et al. Among authors: hushmandi k. Biomed Pharmacother. 2022 Nov;155:113774. doi: 10.1016/j.biopha.2022.113774. Epub 2022 Oct 3. Biomed Pharmacother. 2022. PMID: 36271556 Free article. Review.
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation.
Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, Ertas YN, Mirzaei S, Samarghandian S. Entezari M, et al. Among authors: hushmandi k. Biomed Pharmacother. 2022 Feb;146:112563. doi: 10.1016/j.biopha.2021.112563. Epub 2021 Dec 29. Biomed Pharmacother. 2022. PMID: 35062059 Free article. Review.
Colon cancer transcriptome.
Mokhtari K, Peymani M, Rashidi M, Hushmandi K, Ghaedi K, Taheriazam A, Hashemi M. Mokhtari K, et al. Among authors: hushmandi k. Prog Biophys Mol Biol. 2023 Jul-Aug;180-181:49-82. doi: 10.1016/j.pbiomolbio.2023.04.002. Epub 2023 Apr 13. Prog Biophys Mol Biol. 2023. PMID: 37059270 Review.
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.
Zarrabi A, Perrin D, Kavoosi M, Sommer M, Sezen S, Mehrbod P, Bhushan B, Machaj F, Rosik J, Kawalec P, Afifi S, Bolandi SM, Koleini P, Taheri M, Madrakian T, Łos MJ, Lindsey B, Cakir N, Zarepour A, Hushmandi K, Fallah A, Koc B, Khosravi A, Ahmadi M, Logue S, Orive G, Pecic S, Gordon JW, Ghavami S. Zarrabi A, et al. Among authors: hushmandi k. Cancers (Basel). 2023 Nov 2;15(21):5269. doi: 10.3390/cancers15215269. Cancers (Basel). 2023. PMID: 37958442 Free PMC article. Review.
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free article.
Non-coding RNAs and macrophage interaction in tumor progression.
Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Entezari M, et al. Among authors: hushmandi k. Crit Rev Oncol Hematol. 2022 May;173:103680. doi: 10.1016/j.critrevonc.2022.103680. Epub 2022 Apr 9. Crit Rev Oncol Hematol. 2022. PMID: 35405273 Review.
128 results